Lily of the valley + valerian drops 25 ml.

Description

VALERIAN DROPS
International non-proprietary name:
Registration certificate: UA / 8636/01/01
Term of state registration: from 06/21/2018 to Unlimited
ATC code: C01EX
Price in pharmacies: no information on prices
View analogues
Medicines Control has 100% medicines – this is a convenient service without intrusive advertising. Support us with a monthly fee
VALERIAN DROPS INSTRUCTIONS

for medical use of the drug

lily of the valley and valerian drops

Storage:
active substances: 1 ml of drops contains tinctures of lily of the valley (tinctura convallariae) (1:10) (extractant – ethanol 70%) – 0.5 ml, tinctures of valerian (tinctura valerianae) (1: 5) (extractant – ethanol 70%) – 0 , 5 ml.

Valerian drops Dosage form.

Oral drops.

Basic physical and chemical properties:
liquid from yellow-brown to reddish-brown color, characteristic odor. Precipitation may occur during storage.

Pharmacotherapeutic group
Combined cardiac drugs.
Code ATXC01E X.

Valerian drops Pharmacological properties

Pharmacodynamics
Biologically active substances contained in the roots and rhizomes of valerian (essential oil, valeric acid, borneol, alkaloids, tannins, sugars), reduce the processes of excitation in the central nervous system, increase the effect of other sedatives, hypnotics, analgesics and spasms.

Cardiac glycosides contained in lily of the valley tincture have cardiotonic and hypertensive effects. Under the influence of the drug increases the contractile properties of the myocardium, increases the stroke and cardiac output, slightly reduces dilatation of the heart, arrhythmia, edema. Has a tonic effect on blood vessels, has sedative properties. Glycosides have a diuretic effect.

Pharmacokinetics

Not studied.

Clinical characteristics

Indication.

Cardioneurosis, neurocirculatory dystonia by cardiac type.

Contraindication.

Hypersensitivity to the components of the drug, bradycardia, atrioventricular block, Adams-Stokes-Morgany syndrome, unstable angina, hypercalcemia, hypokalemia, glycoside intoxication, depression and other diseases accompanied by depression of the central nervous system; significant organic changes in the heart muscle and blood vessels, acute myocarditis, endocarditis, severe cardiosclerosis.